Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

CXCL10 overexpression

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

CXCL10 elevation (7)

PD-L1 elevation + CXCL10 elevation + TNFA elevation (1)

CXCL10 elevation (0)

CXCL10 elevation (7)

PD-L1 elevation + CXCL10 elevation + TNFA elevation (1)

CXCL10 elevation (0)

›

CXCL10 overexpression	Glioblastoma	CXCL10 overexpression	Glioblastoma	aflibercept intravitreal Sensitive: C3 – Early Trials aflibercept intravitreal Sensitive : C3	aflibercept intravitreal Sensitive: C3 – Early Trials aflibercept intravitreal Sensitive : C3
CXCL10 overexpression	Renal Cell Carcinoma	CXCL10 overexpression	Renal Cell Carcinoma	pembrolizumab + axitinib Sensitive: C3 – Early Trials pembrolizumab + axitinib Sensitive : C3	pembrolizumab + axitinib Sensitive: C3 – Early Trials pembrolizumab + axitinib Sensitive : C3
CXCL10 overexpression	Colorectal Cancer	CXCL10 overexpression	Colorectal Cancer	cetuximab Sensitive: D – Preclinical cetuximab Sensitive : D	cetuximab Sensitive: D – Preclinical cetuximab Sensitive : D